Diclofenac Sodium and Misoprostol (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Diclofenac Sodium and Misoprostol drug offered from Actavis Pharma, Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Diclofenac Sodium and Misoprostol |
| SUBSTANCE NAME: | DICLOFENAC SODIUM; MISOPROSTOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-11-01 |
| END MARKETING DATE: | 0000-00-00 |
Diclofenac Sodium and Misoprostol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Diclofenac Sodium and Misoprostol from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50; 200(mg/1; ug/1) |
| START MARKETING DATE: | 2012-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-0397_5c953a61-18b4-406b-a911-3b8da8f1a96a |
| PRODUCT NDC: | 0591-0397 |
| APPLICATION NUMBER: | ANDA201089 |
Other DICLOFENAC SODIUM; MISOPROSTOL Pharmaceutical Manufacturers / Labelers:
